FROM SERUM DYSLIPIDEMIA TO MACROPHAGE LIPID REMODELING IN VISCERAL LEISHMANIASIS: CHOLESTEROL TRAFFICKING, IMMUNOMETABOLIC REPROGRAMMING, AND THERAPEUTIC OPPORTUNITIES. (2026). ISIR Journal of Business and Management Studies (ISIRJBMS), 3(5), 45-55. https://isirpublisher.com/index.php/isirjbms/article/view/48